<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100962781</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22270</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Rev Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Rev. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Nature reviews. Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1471-003X</issn>
<issn pub-type="epub">1471-0048</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30410025</article-id>
<article-id pub-id-type="pmc">6396682</article-id>
<article-id pub-id-type="doi">10.1038/s41583-018-0079-z</article-id>
<article-id pub-id-type="manuscript">NIHMS1013728</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Nonsense-mediated RNA decay in the brain: Emerging modulator of neural development and disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jaffrey</surname>
<given-names>Samie</given-names>
</name>
<!--<email>srj2003@med.cornell.edu</email>-->
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wilkinson</surname>
<given-names>Miles F.</given-names>
</name>
<!--<email>mfwilkinson@ucsd.edu</email>-->
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Pharmacology, Weill Medical College, Cornell University, New York, NY 10065</aff>
<aff id="A2"><label>2</label>Department of Reproductive Medicine, University of California, La Jolla, CA 92093</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author contributions</p>
<p id="P2">SRJ and MFW researched data for article, made substantial contribution to discussion of content, writing and review/editing of manuscript before submission.</p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p id="P75"><bold>Competing interests policy</bold> There is NO Competing Interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>19</volume>
<issue>12</issue>
<fpage>715</fpage>
<lpage>728</lpage>
<!--elocation-id from pubmed: 10.1038/s41583-018-0079-z-->
<abstract id="ABS1">
<p id="P3">Steady-state RNA levels are controlled by the balance between RNA synthesis and RNA turnover. A selective RNA turnover mechanism that has received recent attention in neurons is nonsense-mediated RNA decay (NMD). NMD has been shown to influence neural development, neural stem cell differentiation decisions, axon guidance and synaptic plasticity. In humans, NMD factor gene mutations cause some forms of intellectual disability and are associated with neurodevelopmental disorders, including schizophrenia and autism spectrum disorder. Impairments in NMD are linked to neurodegenerative disorders, including amyotrophic lateral sclerosis. We discuss these findings, their clinical implications, and challenges for the future.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>